Biomarkers As A Guide To Therapy In Heart Failure Patients
Sunday, February 1, 2009 - 23:28
in Health & Medicine
A randomized trial suggests that, while using BNP as a marker to guide therapy is not associated with any improvement in all-cause outcome over conventional symptom-guided therapy, there is indeed a benefit in hospital-free survival in heart failure patients under the age of 75.
